DNLI
Denali Therapeutics Inc
19.30$
-3.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -99.6% | +157.1% | -27.5% | +10,416.8% | -96.7% | -0.2% | +224.1% | -65.7% | -22.9% | +62.2% | +60.6% | +3,272.9% | -97.5% | +189.5% | -77.0% | +136.8% | +236.8% | +24.5% | -93.2% | +188.9% | +241.7% | +737.0% | -99.6% | -24,176.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -75.6% | +2.9% | -2.6% | +302.2% | -72.0% | +150.4% | -41.8% | +31.6% | -6.3% | +38.7% | +1.3% | -1.9% | -1.0% | +4.2% | +1.0% | +1.9% | +10.0% | +9.1% | +8.9% | -5.1% | +26.8% | +7.7% | -5.3% | +4.9% | +39.8% | -88.2% | +490.8% | -97.6% | -0.7% | -10.2% | – | – | – | – | +3,248.1% | -97.2% | -0.7% | -96.7% | – | |
| – | – | – | – | – | – | -99.6% | +157.1% | -27.5% | +10,416.8% | -96.7% | -0.2% | +224.1% | -65.7% | -22.9% | +62.2% | +60.6% | +3,272.9% | -97.5% | +189.5% | -77.0% | +136.8% | +236.8% | +24.5% | -93.2% | +188.9% | +241.7% | +737.0% | -99.6% | -24,347.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -39.9% | +10.4% | +2.9% | -2.6% | -0.2% | +12.7% | +150.4% | -41.8% | +31.6% | -6.3% | +38.7% | +1.3% | -1.9% | -1.0% | +4.2% | +1.0% | +1.9% | +10.0% | +9.1% | +8.9% | -5.1% | +26.8% | +7.7% | -5.3% | +4.9% | +39.8% | -24.3% | -8.0% | +20.1% | -0.7% | -14.6% | +7.5% | +1.6% | +16.5% | -11.6% | -0.7% | -4.0% | +6.1% | -6.6% | – | |
| – | -2.2% | +7.5% | +8.9% | +5.9% | +34.3% | +9.9% | +23.8% | +28.2% | +25.0% | -15.7% | +61.9% | -25.6% | -3.0% | +15.4% | +11.3% | +13.1% | +13.9% | +5.2% | +0.6% | +1.4% | +12.6% | +3.6% | -6.1% | +9.9% | +1.1% | +15.4% | -3.8% | -3.0% | -2.2% | +1.9% | -0.2% | -1.0% | +20.5% | -2.3% | +9.9% | +10.0% | +11.2% | -15.1% | +8.3% | – | |
| – | -35.8% | +9.5% | +3.8% | -1.2% | +5.6% | +12.1% | +123.7% | -33.7% | +30.1% | -8.3% | +43.3% | -4.8% | -2.1% | +1.8% | +5.6% | +3.6% | +4.6% | +8.8% | +7.1% | +7.2% | -1.4% | +21.2% | +4.8% | -2.5% | +4.1% | +34.9% | -20.7% | -6.9% | +15.2% | -11.2% | -1.0% | +5.7% | +5.4% | +12.1% | -7.3% | +1.8% | -2.1% | +0.0% | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | -156.9% | – | – | – | – | – | – | – | -129.2% | – | – | – | – | – | – | – | – | – | -166.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | -84.7% | +0.0% | +531.2% | -79.8% | -15.3% | -25.2% | -16.2% | -27.7% | -4.5% | -10.7% | +27.9% | -0.5% | +107.3% | +58.1% | +59.1% | +216.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -150.3% | – | – | – | – | – | – | – | -128.5% | – | – | – | – | – | – | – | – | – | -154.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -280.0% | – | -29.1% | +1,369.6% | -356.1% | – | +7.4% | -173.5% | – | – | +7,729.3% | -100.3% | – | – | – | -98.7% | +6,962.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -150.3% | – | – | – | – | – | – | – | -128.6% | – | – | – | – | – | – | – | – | – | -154.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -152.0% | – | – | – | – | – | – | – | -128.1% | – | – | – | – | – | – | – | – | – | -152.3% | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.